Novavax Inc (NVAX)
9.35
-0.26
(-2.71%)
USD |
NASDAQ |
Nov 01, 16:00
9.42
+0.07
(+0.75%)
After-Hours: 20:00
Novavax Debt to Equity Ratio: -0.3911 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.3911 |
| March 31, 2024 | -0.1943 |
| December 31, 2023 | -0.2344 |
| September 30, 2023 | -0.2471 |
| June 30, 2023 | -0.2217 |
| March 31, 2023 | -0.1863 |
| December 31, 2022 | -0.7749 |
| September 30, 2022 | -0.5734 |
| June 30, 2022 | -0.7775 |
| March 31, 2022 | 4.957 |
| December 31, 2021 | -0.9198 |
| September 30, 2021 | 0.7004 |
| June 30, 2021 | 0.4329 |
| March 31, 2021 | 0.3103 |
| December 31, 2020 | 0.5134 |
| September 30, 2020 | 3.022 |
| June 30, 2020 | 1.741 |
| March 31, 2020 | -13.39 |
| December 31, 2019 | -1.724 |
| September 30, 2019 | -1.687 |
| June 30, 2019 | -1.725 |
| March 31, 2019 | -2.122 |
| December 31, 2018 | -1.901 |
| September 30, 2018 | -2.517 |
| June 30, 2018 | -3.631 |
| Date | Value |
|---|---|
| March 31, 2018 | -3.201 |
| December 31, 2017 | -3.124 |
| September 30, 2017 | -4.280 |
| June 30, 2017 | -5.368 |
| March 31, 2017 | -10.88 |
| December 31, 2016 | -57.04 |
| September 30, 2016 | 6.348 |
| June 30, 2016 | 2.868 |
| March 31, 2016 | 1.702 |
| December 31, 2015 | 0.0013 |
| September 30, 2015 | 0.0015 |
| June 30, 2015 | 0.0018 |
| March 31, 2015 | 0.0021 |
| December 31, 2014 | 0.0043 |
| September 30, 2014 | 0.0052 |
| June 30, 2014 | 0.0055 |
| March 31, 2014 | 0.009 |
| December 31, 2013 | 0.0093 |
| September 30, 2013 | 0.0104 |
| June 30, 2013 | 0.0321 |
| March 31, 2013 | 0.0217 |
| December 31, 2012 | 0.0113 |
| September 30, 2012 | 0.0155 |
| June 30, 2012 | 0.0065 |
| March 31, 2012 | 0.0075 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-13.39
Minimum
Mar 2020
4.957
Maximum
Mar 2022
-0.4188
Average
-0.2217
Median
Jun 2023
Debt to Equity Ratio Benchmarks
| Pfizer Inc | 0.7831 |
| Moderna Inc | 0.00 |
| BioCryst Pharmaceuticals Inc | -1.700 |
| Eli Lilly and Co | 2.185 |
| AIM ImmunoTech Inc | 0.4322 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.819B |
| Total Liabilities (Quarterly) | 2.250B |
| Shareholders Equity (Quarterly) | -431.71M |
| Current Ratio | 1.039 |
| Net Debt Paydown Yield | -0.02% |